USFDA conducts inspection at Alembic Pharmaceuticals’ API Facility at Karkhadi

18 May 2018 Evaluate

The United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals’ API Facility located at Karkhadi from May 14, 2018 to May 18, 2018. This was a scheduled inspection and at the end of the inspection, the US FDA issued a Form 483 with one observation.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company now has a total of 71 ANDA approvals (63 final approvals and 8 tentative approvals) from USFDA.

Alembic Pharma Share Price

762.55 -6.00 (-0.78%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×